Analyzing TransEnterix (TRXDW) and Its Competitors

Profitability

This table compares TransEnterix and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransEnterix	-2,149.15%	-83.74%	-64.94%
TransEnterix Competitors	-672.41%	-133.75%	-59.01%

Volatility and Risk

TransEnterix has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s rivals have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.

Earnings and Valuation

This table compares TransEnterix and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TransEnterix	$8.53 million	-$154.20 million	-0.04
TransEnterix Competitors	$58.84 million	-$32.15 million	4.18

TransEnterix’s rivals have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

8.2% of TransEnterix shares are held by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 3.1% of TransEnterix shares are held by insiders. Comparatively, 18.1% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

TransEnterix rivals beat TransEnterix on 7 of the 9 factors compared.

TransEnterix Company Profile

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.